NO981241L - Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse - Google Patents

Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse

Info

Publication number
NO981241L
NO981241L NO981241A NO981241A NO981241L NO 981241 L NO981241 L NO 981241L NO 981241 A NO981241 A NO 981241A NO 981241 A NO981241 A NO 981241A NO 981241 L NO981241 L NO 981241L
Authority
NO
Norway
Prior art keywords
optionally substituted
derivatives
pharmaceutical preparations
preparations containing
heteroaryl substituted
Prior art date
Application number
NO981241A
Other languages
English (en)
Other versions
NO981241D0 (no
Inventor
Kazumi Kikuchi
Akira Toyoshima
Toshio Okazaki
Masahiro Takanashi
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO981241D0 publication Critical patent/NO981241D0/no
Publication of NO981241L publication Critical patent/NO981241L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Heteroarylsubstituerte akryloyl-guanidinderivater med formel (I) og deres salter. hvori ring A representerer en 5-leddet eller 6-leddet heteroarylgruppe som eventuelt kan være substituert og eventuelt være kondensert med én eller to benzenringer; ring B representerer en. eventuelt substituert arylgruppe; og R x representerer et hydrogenatom, et halo-genatom eller en lavere alkylgruppe som eventuelt er substituert med ett eller flere halogenatomer. Fordi de virker som en Na/Hutvekslingsinhibitor er. derivatene og deres salter anvendelige i medisinen, spesielt ved forebyggelse, behandling og diagnose av forskjellige sykdommer som forårsakes av Na/Hutvekslingen, slik som hypertensjon, arytmi, angina pectoris, arterio-sklerose, diabetiske komplikasjoner etc.
NO981241A 1995-09-20 1998-03-19 Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse NO981241L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24171695 1995-09-20
PCT/JP1996/002696 WO1997011055A1 (en) 1995-09-20 1996-09-19 Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof

Publications (2)

Publication Number Publication Date
NO981241D0 NO981241D0 (no) 1998-03-19
NO981241L true NO981241L (no) 1998-05-20

Family

ID=17078479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981241A NO981241L (no) 1995-09-20 1998-03-19 Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse

Country Status (13)

Country Link
EP (1) EP0861831A4 (no)
KR (1) KR19990063589A (no)
CN (1) CN1196721A (no)
AU (1) AU702092B2 (no)
BR (1) BR9610530A (no)
CA (1) CA2232497A1 (no)
CZ (1) CZ84098A3 (no)
HU (1) HUP9901336A3 (no)
NO (1) NO981241L (no)
PL (1) PL326033A1 (no)
SK (1) SK35198A3 (no)
WO (1) WO1997011055A1 (no)
ZA (1) ZA967800B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004781A1 (en) * 1995-08-02 1997-02-13 Smithkline Beecham Corporation Endothelin receptor antagonists
WO1998039300A1 (en) * 1997-03-06 1998-09-11 Toa Eiyo Ltd. CYCLOALKA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND DRUGS CONTAINING THE SAME
HK1047928A1 (zh) * 1999-08-23 2003-03-14 Smithkline Beecham Corporation 脂肪酸合成酶抑制剂
ATE341343T1 (de) 2000-12-26 2006-10-15 Sankyo Co Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel
BRPI0512213A (pt) 2004-06-16 2008-02-19 Wyeth Corp método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
CA2578600A1 (en) 2004-06-16 2006-01-26 Wyeth Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase
CA2593515A1 (en) 2005-01-14 2006-07-20 Wyeth Amino-imidazolones for the inhibition of beta-secretase
KR20070107062A (ko) 2005-02-01 2007-11-06 와이어쓰 β-세크리타제의 억제제로서의 아미노-피리딘
WO2006088694A1 (en) 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
EP1848692A1 (en) 2005-02-14 2007-10-31 Wyeth AZOLYLACYLGUANIDINES AS ß-SECRETASE INHIBITORS
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
WO2007005404A1 (en) 2005-06-30 2007-01-11 Wyeth AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION
EP1928841A1 (en) 2005-09-26 2008-06-11 Wyeth a Corporation of the State of Delaware Amino-5- ý4- (difluoromethoxy) phenyl¨-5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
CL2008000791A1 (es) 2007-03-23 2008-05-30 Wyeth Corp Compuestos derivados de 2-amino-5-(4-difluorometoxi-fenil)-5-fenil-imidazolidin-4-ona; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la actividad bace excesiva, tales como enferm
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ES2089600T3 (es) * 1992-02-15 1996-10-01 Hoechst Ag Benzoilguanidina sustituida en 3,5, con efecto antiarritmico y efecto inhibidor de la proliferacion de celulas.
JP3162572B2 (ja) * 1993-04-28 2001-05-08 住友製薬株式会社 インドロイルグアニジン誘導体
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
JPH0959245A (ja) * 1995-08-25 1997-03-04 Yamanouchi Pharmaceut Co Ltd Ｎ−（２−プロペノイル）グアニジン誘導体

Also Published As

Publication number Publication date
NO981241D0 (no) 1998-03-19
CA2232497A1 (en) 1997-03-27
PL326033A1 (en) 1998-08-17
HUP9901336A2 (hu) 1999-08-30
WO1997011055A1 (en) 1997-03-27
MX9802238A (es) 1998-08-30
AU702092B2 (en) 1999-02-11
CZ84098A3 (cs) 1998-09-16
AU7000796A (en) 1997-04-09
KR19990063589A (ko) 1999-07-26
ZA967800B (en) 1997-04-03
SK35198A3 (en) 1999-06-11
EP0861831A1 (en) 1998-09-02
EP0861831A4 (en) 1998-11-11
BR9610530A (pt) 1999-07-06
CN1196721A (zh) 1998-10-21
HUP9901336A3 (en) 2000-02-28

Similar Documents

Publication Publication Date Title
NO981241L (no) Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DE69532216D1 (de) 1-Acetyl-5-Bromo-4,6-Dimethylindolin
NO20004624D0 (no) Benzensulfonamid-derivater og deres anvendelse som medikamenter
FR2401159A1 (fr) Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
NO2006003I2 (no) ÄR-(R*,R*)Ü-N-Ä3-Ä1-Ä5,6-dihydro-4-hydroksy-2-okso-6-(2-fenyletyl)-6-propyl-2H-pyran-3-ylÜpropylÜfenylÜ5-(trifluormetyl)-2-pyridinsulfonamid eller et farmasotisk salt derav= Tipranavir eller et farmasotisk salt derav
ATE60579T1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
NO951147L (no) Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel
NO920432D0 (no) Cykloalkylenazoler, fremgangsmaate for fremstilling av disse, farmasoeytiske preparater som inneholder disse, saavel som deres anvendelse for fremstilling av legemidler
DE69103630D1 (de) Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.
NO20022456L (no) Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon
TR199700704A2 (xx) �kame edilmi� indanilidinasetilguanidin'leri, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnoz maddesi olarak kullan�lmalar� ve bunlar� ihtiva eden ila�lar.
AU7812087A (en) Benzhydryloxyethylpiperidine derivatives, process for their preparation and pharmaceutical compositions in which they are present
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
NO20051833L (no) 4-(3,5-dicyanofenoksy)pyrazolderivater for anvendelse som transkriptasemodulatorer ved behandling av IA HIV.
RU94033470A (ru) Циклогексановые производные, фармкомпозиция на их основе и способ лечения
NO881279D0 (no) Nye 2-tienyoksyeddiksyrederivater, en fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder dem.
ATE4541T1 (de) Alkyl- und cycloalkylsubstituierte 2-(2-(2hydroxy-3-tert.-butylamino-propoxy)-5-acylamino phenyl)-1,3,4-oxadiazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen.
DK176788A (da) Thienyloxyeddikesyrederivater, fremgangsmaade til fremstilling af saadanne derivater og laegemiddel indeholdende disse
TH20764A (th) อนุพันธ์เฮเทอโรไซคลิคของแอไซโลน